Brain Cancer Trial, Recruiting (NCT05576103)

Brain Cancer Trial, Recruiting NCT05576103 Sponsor: Jona Hattangadi-Gluth Condition: Brain Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05576103 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Brain Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older
You are generally able to carry out normal daily activities with at least some level of independence (confirm with trial site)
Your doctors expect you to live for at least 1 year or more
You have a primary brain tumor and are scheduled to receive a course of targeted radiation treatment to part of the brain
You are able to complete memory and thinking skills tests during the study

Who may not be able to join:

You are unable to have an MRI scan with a contrast dye injection (for example, due to a pacemaker, severe kidney problems, or allergy to the contrast material)
You have previously received radiation treatment to the brain

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 16 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 858-822-6575

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05576103

Sponsor: Jona Hattangadi-Gluth

Phase: Not Applicable

Status: Recruiting

Condition: Brain Cancer

Trial contact: 858-822-6575

More information: https://clinicaltrials.gov/study/NCT05576103

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older
You are generally able to carry out normal daily activities with at least some level of independence (confirm with trial site)
Your doctors expect you to live for at least 1 year or more
You have a primary brain tumor and are scheduled to receive a course of targeted radiation treatment to part of the brain
You are able to complete memory and thinking skills tests during the study

Who may not be able to join:

You are unable to have an MRI scan with a contrast dye injection (for example, due to a pacemaker, severe kidney problems, or allergy to the contrast material)
You have previously received radiation treatment to the brain

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 16 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Jona Hattangadi-Gluth

Registry

ClinicalTrials.gov

Start date

1 January 2015

Est. completion

1 December 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Longitudinal changes in imaging biomarker volume (cc) from volumetric MR imaging; Longitudinal changes in imaging biomarker mean diffusivity (MD) in white matter from DTI imaging; Longitudinal changes in imaging biomarker fractional anisotropy (FA) in white matter from DTI imaging; Change in Memory after RT; Change in Executive Functioning after RT; Change in Attention/Processing Speed after RT; Change in Language functioning after RT; Change in Fine Motor Skills after RT; Change in health-related quality of life (hrQoL) from baseline to 5 years after RT

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov